Cholera

被引:431
作者
Harris, Jason B. [1 ,2 ]
LaRocque, Regina C. [1 ,3 ]
Qadri, Firdausi [5 ]
Ryan, Edward T. [1 ,3 ,6 ]
Calderwood, Stephen B. [1 ,3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[4] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA
[5] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh
[6] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
基金
比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;
关键词
ENTEROTOXIGENIC ESCHERICHIA-COLI; SINGLE-DOSE CIPROFLOXACIN; LATEX AGGLUTINATION ASSAY; ORAL REHYDRATION SOLUTION; VACCINE CVD 103-HGR; VIBRIO-CHOLERAE; WHOLE-CELL; FIELD TRIAL; PROTECTIVE EFFICACY; IMMUNE-RESPONSES;
D O I
10.1016/S0140-6736(12)60436-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120 000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0.2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed.
引用
收藏
页码:2466 / 2476
页数:11
相关论文
共 148 条
[1]   Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double blind clinical trial [J].
Alam, NH ;
Majumder, RN ;
Fuchs, GJ .
LANCET, 1999, 354 (9175) :296-299
[2]   Symptomatic hyponatremia during treatment of dehydrating diarrheal disease with reduced osmolarity oral rehydration. solution [J].
Alam, Nur H. ;
Yunus, Mohammed ;
Faruque, Abu S. G. ;
Gyr, Niklaus ;
Sattar, Samima ;
Parvin, Shahanaz ;
Ahmed, Jamal U. ;
Salam, Mohammed A. ;
Sack, David A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (05) :567-573
[3]  
ALBERT MJ, 1993, LANCET, V341, P704
[4]   Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis [J].
Ali, M ;
Emch, M ;
von Seidlein, L ;
Yunus, M ;
Sack, DA ;
Rao, M ;
Holmgren, J ;
Clemens, JD .
LANCET, 2005, 366 (9479) :44-49
[5]   COMPARISON OF A LATEX AGGLUTINATION ASSAY AND AN ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR DETECTING CHOLERA-TOXIN [J].
ALMEIDA, RJ ;
HICKMANBRENNER, FW ;
SOWERS, EG ;
PUHR, ND ;
FARMER, JJ ;
WACHSMUTH, IK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (01) :128-130
[6]   Transmission dynamics and control of cholera in Haiti: an epidemic model [J].
Andrews, Jason R. ;
Basu, Sanjay .
LANCET, 2011, 377 (9773) :1248-1255
[7]   Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults [J].
Anh, Dang Duc ;
Canh, Do Gia ;
Lopez, Anna Lena ;
Thiem, Vu Dinh ;
Long, Phan Thi ;
Son, Nguyen Hong ;
Deen, Jacqueline ;
von Seidlein, Lorenz ;
Carbis, Rodney ;
Han, Seung Hyun ;
Shin, Seong Hye ;
Attridge, Stephen ;
Holmgren, Jan ;
Clemens, John .
VACCINE, 2007, 25 (06) :1149-1155
[8]   Use of Oral Cholera Vaccines in an Outbreak in Vietnam: A Case Control Study [J].
Dang Duc Anh ;
Lopez, Anna Lena ;
Vu Dinh Thiem ;
Grahek, Shannon L. ;
Tran Nhu Duong ;
Park, Jin Kyung ;
Kwon, Hye Jung ;
Favorov, Michael ;
Nguyen Tran Hien ;
Clemens, John D. .
PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (01)
[9]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586
[10]  
[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117